NO895217L - Substituerte pyrido(2,3-d)pyrimidiner. - Google Patents

Substituerte pyrido(2,3-d)pyrimidiner.

Info

Publication number
NO895217L
NO895217L NO89895217A NO895217A NO895217L NO 895217 L NO895217 L NO 895217L NO 89895217 A NO89895217 A NO 89895217A NO 895217 A NO895217 A NO 895217A NO 895217 L NO895217 L NO 895217L
Authority
NO
Norway
Prior art keywords
pyrimidines
substituted pyrido
pyrido
substituted
Prior art date
Application number
NO89895217A
Other languages
English (en)
Norwegian (no)
Other versions
NO895217D0 (no
Inventor
Walter Huebsch
Rolf Angebauer
Peter Fey
Thomas Philipps
Hilmar Bischoff
Dieter Petzinna
Delf Schmidt
Guenter Thomas
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3900363A external-priority patent/DE3900363A1/de
Priority claimed from IT8921215A external-priority patent/IT8921215A0/it
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO895217D0 publication Critical patent/NO895217D0/no
Publication of NO895217L publication Critical patent/NO895217L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO89895217A 1989-01-07 1989-12-22 Substituerte pyrido(2,3-d)pyrimidiner. NO895217L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3900363A DE3900363A1 (de) 1989-01-07 1989-01-07 Neue substituierte pyrido(2,3,-d)pyrimidine
IT8921215A IT8921215A0 (it) 1989-07-18 1989-07-18 Pirido(2,3 d)pirimidine sostituite.

Publications (2)

Publication Number Publication Date
NO895217D0 NO895217D0 (no) 1989-12-22
NO895217L true NO895217L (no) 1990-07-09

Family

ID=25876617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895217A NO895217L (no) 1989-01-07 1989-12-22 Substituerte pyrido(2,3-d)pyrimidiner.

Country Status (17)

Country Link
US (1) US5075311A (es)
EP (1) EP0378850B1 (es)
JP (1) JPH02247179A (es)
KR (1) KR900011768A (es)
CN (1) CN1043938A (es)
AU (1) AU618158B2 (es)
CA (1) CA2007233A1 (es)
DE (1) DE58907412D1 (es)
DK (1) DK3290A (es)
ES (1) ES2063107T3 (es)
FI (1) FI900038A (es)
HU (1) HUT53640A (es)
IE (1) IE900058L (es)
IL (1) IL92970A (es)
NO (1) NO895217L (es)
NZ (1) NZ232013A (es)
PT (1) PT92793A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145959A (en) * 1989-07-18 1992-09-08 Bayer Aktiengesellschaft Substituted pyrido (2,3-d) pyrimidines as intermediates
DE4035479A1 (de) * 1990-11-08 1992-05-14 Basf Ag Substituierte pyrido (2,3-d)pyrimidin-2,4(1h,3h)-dione
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
BR9810508A (pt) 1997-07-03 2000-09-05 Du Pont Pharm Co Composto, composição farmacêutica e método de tratamento de uma desordem
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US7420059B2 (en) 2003-11-20 2008-09-02 Bristol-Myers Squibb Company HMG-CoA reductase inhibitors and method
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP2266984A1 (en) * 2009-06-26 2010-12-29 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis
CN108164517A (zh) * 2018-02-12 2018-06-15 李化绪 (2-甲基环己烷-1-基)亚氨基类化合物及其在高脂血症药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE114027C (es) *
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis

Also Published As

Publication number Publication date
ES2063107T3 (es) 1995-01-01
HUT53640A (en) 1990-11-28
IL92970A0 (en) 1990-09-17
US5075311A (en) 1991-12-24
IL92970A (en) 1994-01-25
DK3290D0 (da) 1990-01-05
DK3290A (da) 1990-07-08
CA2007233A1 (en) 1990-07-07
HU900049D0 (en) 1990-03-28
KR900011768A (ko) 1990-08-02
IE900058L (en) 1990-07-07
CN1043938A (zh) 1990-07-18
JPH02247179A (ja) 1990-10-02
FI900038A (fi) 1990-07-08
NO895217D0 (no) 1989-12-22
NZ232013A (en) 1991-11-26
FI900038A0 (fi) 1990-01-04
EP0378850A2 (de) 1990-07-25
EP0378850A3 (de) 1991-09-11
DE58907412D1 (de) 1994-05-11
EP0378850B1 (de) 1994-04-06
PT92793A (pt) 1990-07-31
AU4698889A (en) 1990-07-12
AU618158B2 (en) 1991-12-12

Similar Documents

Publication Publication Date Title
DE59101477D1 (de) Thieno[2,3-d]pyrimidinderivate.
NO900619D0 (no) Substituerte 1,3-okstiolaner.
NO904511L (no) Pyrimidiner.
DE3769191D1 (de) Cycloalkano(1,2-b)indol-sulfonamide.
FI920674A0 (fi) Laogkalorihaltiga, graeddaktiga naeringsprodukter med mjuka organoleptiska egenskaper.
FI905500A0 (fi) Individualiserade, med polykarboxylsyra tvaerbundna fibrer.
FI896128A0 (fi) Slang- eller roerformig, elastisk hylsa med mikrobicida egenskaper foer urinroerkatetrar.
DE69000743D1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-thione.
FI900837A0 (fi) Dragked med tvao skruvgaengformade, av plastmonofilament framstaellda spaerrorganrader.
NO895217D0 (no) Substituerte pyrido(2,3-d)pyrimidiner.
FI923290A0 (fi) Imidazo (2,1-b)bensotiazol-3 -acetamidderivat.
NO893491D0 (no) 2-aza-4-(alkoksykarbonyl) spiro (4,5) dekan-3-on.
DK232387A (da) Diastereoisomere tetrahydropyrido (2,3-d) pyrimi- din derivativer
DE3769721D1 (de) 4(3h)-oxo-5,6,7,8-tetrahydropyrido(2,3-d)pyrimidinderivate.
FI906270A (fi) Imidazo/4,5-c/pyridiner som antiosteoporotiska aemnen.
ATE121400T1 (de) Pyridyl-methylenamino-1,2,4-triazinone.
DE3276808D1 (de) Pyrido (2,3-d) pyrimidines
DE69004844D1 (de) Pyrimidin-Derivate.
FI903792A0 (fi) Nickel-kopparskaerstenkonverter, i vilken anvaends kvaeveanrikad blaestring.
ATE115144T1 (de) Antivirale tetrahydroimidazo(1,4>benzodiazepine.
IT8921215A0 (it) Pirido(2,3 d)pirimidine sostituite.
DE3776199D1 (de) 2,3-dihydro-1-(8-methyl-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4(1h)-pyridinon.
ATE103917T1 (de) Neue substituierte pyrido(2,3-d)pyrimidine.
FI905745A0 (fi) Pyridin-2,4 och pyridin-2,5 -dikarboxylsyra-amider, foerfarande foer deras framstaellning och deras anvaendning.
ZA9075B (en) New substituted pyrido(2,3-d)pyrimidines